CS
Chandrasekaran Surendrababu
About Chandrasekaran Surendrababu
Data last updated:
Chandrasekaran Surendrababu is a Managing Director at Sugajeevan Multispeciality Hospital Private Limited (since 2019). The company operates in Healthcare. Sugajeevan Multispeciality Hospital Private Limited reported revenue of ₹9.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sugajeevan Multispeciality Hospital Private Limited U85300TN2019PTC128037 | Managing Director | 14 Mar 2019 | 2019 | ₹9.5 Lakh (FY 2025) | Active |
Board colleagues of Chandrasekaran Surendrababu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajakumar Veerasamy | 08379989 | Sugajeevan Multispeciality Hospital Private Limited | Director |
| Senthilnathan Kalaiselvan | 08380013 | Sugajeevan Multispeciality Hospital Private Limited | Director |
| Thirumalaipandiyan | 08380015 | Sugajeevan Multispeciality Hospital Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrasekaran Surendrababu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrasekaran Surendrababu
Chandrasekaran Surendrababu currently holds 1 directorship: Sugajeevan Multispeciality Hospital Private Limited (Managing Director, since 14 Mar 2019, revenue ₹9.5 Lakh (FY 2025)).
Chandrasekaran Surendrababu was first appointed on 14 Mar 2019 as Managing Director at Sugajeevan Multispeciality Hospital Private Limited.
The current boards of Chandrasekaran Surendrababu's companies include Rajakumar Veerasamy (Sugajeevan Multispeciality Hospital Private Limited), Senthilnathan Kalaiselvan (Sugajeevan Multispeciality Hospital Private Limited), Thirumalaipandiyan (Sugajeevan Multispeciality Hospital Private Limited).